Videos
EXPLORE44's Approach to Rare Disease Treatment for Duchenne Muscular Dystrophy: Steve Hughes, MD
August 30th 2023The chief medical officer at Avidity Biosciences discussed the phase 1/2 EXPLORE44 trial, assessing an investigational treatment for Duchenne muscular dystrophy, and highlighted the potential of the treatment based on the recent FDA orphan drug and fast track designations. [WATCH TIME: 4 minutes]
Capabilities of Deep Brain Stimulation to Modulate Late-Stage Neuroplasticity: Kenneth Baker, PhD
August 30th 2023The associate staff member in the department of neurology at Cleveland Clinic discussed the major take-home points and post-hoc findings from a positive study of deep brain stimulation in poststroke patients. [WATCH TIME: 3 minutes]
Shifting to a Collaborative Approach to Conquer Challenges in Progressive MS: Anne H. Cross, MD
August 29th 2023The professor of neurology at Washington University School of Medicine discussed the growing sense of hope among patients with progressive multiple sclerosis as providers gain an understanding in treating this form of the disease. [WATCH TIME: 3 minutes]
Exploring Potential Therapeutic Opportunities for GammaTile in Neurosurgery: Matthew Shepard, MD
August 28th 2023The neurosurgeon at Allegheny Health Network discussed the current uses of GammaTile following tumor removal, and the research needed to unlock greater potential. [WATCH TIME: 3 minutes]
Potential Avenues for Remyelination in Multiple Sclerosis: Bruce Bebo, PhD
August 23rd 2023The executive vice president of the National MS Society provided perspective on the challenges with remyelinating strategies for patients with MS, and the progress that’s been made thus far. [WATCH TIME: 4 minutes]
Clinical Pearls for Navigating Neurological Diagnoses: Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
August 23rd 2023The assistant professor at Hunter College talked about the importance of prioritizing accurate localization, appropriate diagnostic tests, and patient communication for effective neurological diagnosis, prognosis, and treatment. [WATCH TIME: 3 minutes]
Exploring the Potential of Deep Brain Stimulation in Poststroke Recovery: Kenneth Baker, PhD
August 22nd 2023The associate staff member in the department of neurology at Cleveland Clinic provided background on a recently published phase 1 trial showing benefits of DBS for chonic poststroke motor rehabilitation. [WATCH TIME: 3 minutes]
A 3-Step Strategy for Enhancing Migraine Patient Care: Bert B. Vargas, MD, FAHS, FAAN
August 21st 2023The associate vice president of neuroscience, US Medical Affairs at Eli Lilly talked about the "Think Talk Treat Migraine" program and the 3 vital actions for providers take to improve migraine care for their patients. [WATCH TIME: 3 minutes]
Retinal Vasculature Changes in Migraine With Aura: Katherine Podraza, MD, PhD
August 18th 2023The headache specialist at the Hartford Healthcare Headache Center discussed findings from a study that revealed altered retinal vasculature in individuals with migraine with aura, indicating potential retinal biomarkers for disease progression. [WATCH TIME: 4 minutes]
Empowering Behavior Change in Migraine Through Motivational Interviewing: Elizabeth Seng, PhD
August 16th 2023The associate professor at Yeshiva University and Albert Einstein College of Medicine discussed the significance of motivational interviewing as a means for providers to engage with their patients and the harmful impact of societal stereotypes on individuals with migraine. [WATCH TIME: 5 minutes]
Navigating Communication Barriers in Migraine Treatment: Bert B. Vargas, MD, FAHS, FAAN
August 15th 2023The associate vice president of neuroscience, US Medical Affairs at Eli Lilly discussed the complexities of migraine treatment, highlighting the need to address communication barriers between healthcare providers and patients. [WATCH TIME: 5 minutes]
Advancing Care With Exon Skipping Therapies for Duchenne Muscular Dystrophy: Vamshi Rao, MD
August 15th 2023The associate professor of pediatrics in neurology and epilepsy at Northwestern University Feinberg School of Medicine discussed the FDA-cleared phase 1/2 trial of an exon 50 skipping therapy to address the specific mutations causing Duchenne muscular dystrophy. [WATCH TIME: 6 minutes]
Building a Healthy Learning Environment for Young Medical Professionals: Alexandria Reynolds, PhD
August 14th 2023The undergraduate program director at the University of South Carolina discussed the shift in teaching strategies for those in neurology and why more hands-on experience serves students better. [WATCH TIME: 5 minutes]
Seeking Clarity in Patient Stratification of Parkinson Disease: Mazen Elkurd, DO
August 14th 2023The director of the Movement Disorders Center at Baylor University Medical Center in Dallas, a part of Baylor Scott & White Health, talked about the dilemma of stratifying patients with Parkinson disease based on various criteria and emphasized the need for a consensus on classification. [WATCH TIME: 3 minutes]
Empowering Primary Care in Migraine Management for Women: Bert B. Vargas, MD, FAHS, FAAN
August 11th 2023The associate vice president of neuroscience, US Medical Affairs at Eli Lilly talked about the impact of migraine on women and the importance of primary care in managing this widespread condition. [WATCH TIME: 4 minutes]
Proper Ways to Engage Underserved Populations in Pain Medicine: Burel Goodin, PhD
August 10th 2023The professor of anesthesiology at Washington University in St. Louis provided perspective on the respect and approach that comes with conducting research in underserved or impoverished communities. [WATCH TIME: 4 minutes]
